RxDoctor Payments Data

Megan Mantica, MD

Neurology · Pittsburgh, PANPI 1568704625

Payments from drug & device makers

$110,239in general payments, 2019–2025

Across 71 payments — averaging $1552.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Incyte Corporation$77K
  • Jazz Pharmaceuticals Inc.$28K
  • Novocure GmbH$6K

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Incyte Corporation64$76,650
Jazz Pharmaceuticals Inc.4$27,800
Novocure GmbH3$5,789

How this compares

$110,239 in reported general payments places this provider in the 85th percentile of 941 neurology providers in Pennsylvania.

See all neurology providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$33,652
Medicare patients
122
Services billed
301

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Levetiracetam70$2,545
Lacosamide22$1,373
Dexamethasone67$1,340
Carbamazepine ErCarbamazepine11$1,286
Duloxetine Hcl18$348
Ondansetron Hcl37$251
Gabapentin20$187
Divalproex Sodium21$179
Famotidine13$134
Lamotrigine19$131
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim17$45

Paid to pharmacies, not to this prescriber.

Other neurology in Pittsburgh

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →